246 related articles for article (PubMed ID: 2011576)
1. The Ca2(+)-binding glycoprotein SPARC modulates cell cycle progression in bovine aortic endothelial cells.
Funk SE; Sage EH
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2648-52. PubMed ID: 2011576
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelial cell proliferation by SPARC is mediated through a Ca(2+)-binding EF-hand sequence.
Sage EH; Bassuk JA; Yost JC; Folkman MJ; Lane TF
J Cell Biochem; 1995 Jan; 57(1):127-40. PubMed ID: 7721952
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of SPARC and cationic SPARC peptides on DNA synthesis by endothelial cells and fibroblasts.
Funk SE; Sage EH
J Cell Physiol; 1993 Jan; 154(1):53-63. PubMed ID: 8419407
[TBL] [Abstract][Full Text] [Related]
4. SPARC antagonizes the effect of basic fibroblast growth factor on the migration of bovine aortic endothelial cells.
Hasselaar P; Sage EH
J Cell Biochem; 1992 Jul; 49(3):272-83. PubMed ID: 1644864
[TBL] [Abstract][Full Text] [Related]
5. Modulation of endothelial cell shape by SPARC does not involve chelation of extracellular Ca2+ and Mg2+.
Sage EH
Biochem Cell Biol; 1992 Jan; 70(1):56-62. PubMed ID: 1581032
[TBL] [Abstract][Full Text] [Related]
6. SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix.
Sage H; Vernon RB; Funk SE; Everitt EA; Angello J
J Cell Biol; 1989 Jul; 109(1):341-56. PubMed ID: 2745554
[TBL] [Abstract][Full Text] [Related]
7. Regulation of gene expression by SPARC during angiogenesis in vitro. Changes in fibronectin, thrombospondin-1, and plasminogen activator inhibitor-1.
Lane TF; Iruela-Arispe ML; Sage EH
J Biol Chem; 1992 Aug; 267(23):16736-45. PubMed ID: 1379603
[TBL] [Abstract][Full Text] [Related]
8. Secretion of SPARC by endothelial cells transformed by polyoma middle T oncogene inhibits the growth of normal endothelial cells in vitro.
Sage EH
Biochem Cell Biol; 1992 Jul; 70(7):579-92. PubMed ID: 1449724
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of PDGF-stimulated and matrix-mediated proliferation of human vascular smooth muscle cells by SPARC is independent of changes in cell shape or cyclin-dependent kinase inhibitors.
Motamed K; Funk SE; Koyama H; Ross R; Raines EW; Sage EH
J Cell Biochem; 2002; 84(4):759-71. PubMed ID: 11835401
[TBL] [Abstract][Full Text] [Related]
10. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
11. Functional mapping of SPARC: peptides from two distinct Ca+(+)-binding sites modulate cell shape.
Lane TF; Sage EH
J Cell Biol; 1990 Dec; 111(6 Pt 2):3065-76. PubMed ID: 2269665
[TBL] [Abstract][Full Text] [Related]
12. SPARC mediates focal adhesion disassembly in endothelial cells through a follistatin-like region and the Ca(2+)-binding EF-hand.
Murphy-Ullrich JE; Lane TF; Pallero MA; Sage EH
J Cell Biochem; 1995 Feb; 57(2):341-50. PubMed ID: 7539008
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.
Gupta SK; Singh JP
J Cell Biol; 1994 Nov; 127(4):1121-7. PubMed ID: 7962072
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis.
Sage EH; Reed M; Funk SE; Truong T; Steadele M; Puolakkainen P; Maurice DH; Bassuk JA
J Biol Chem; 2003 Sep; 278(39):37849-57. PubMed ID: 12867428
[TBL] [Abstract][Full Text] [Related]
15. SPARC (secreted protein acidic and rich in cysteine) regulates endothelial cell shape and barrier function.
Goldblum SE; Ding X; Funk SE; Sage EH
Proc Natl Acad Sci U S A; 1994 Apr; 91(8):3448-52. PubMed ID: 8159767
[TBL] [Abstract][Full Text] [Related]
16. Loss of insulin-like growth factor I receptor-dependent expression of p107 and cyclin A in cells that lack the extracellular matrix protein secreted protein acidic and rich in cysteine.
Basu A; Rodeck U; Prendergast GC; Howe CC
Cell Growth Differ; 1999 Nov; 10(11):721-8. PubMed ID: 10593648
[TBL] [Abstract][Full Text] [Related]
17. The effect of sulfasalazine on bovine endothelial cell proliferation and cell cycle phase distribution. Comparison with olsalazine, 5-aminosalicylic acid, and sulfapyridine.
Sharon P; Drab EA; Linder JS; Weidman SW; Sabesin SM; Rubin DB
J Lab Clin Med; 1992 Jan; 119(1):99-107. PubMed ID: 1345796
[TBL] [Abstract][Full Text] [Related]
18. Specific interaction of SPARC with endothelial cells is mediated through a carboxyl-terminal sequence containing a calcium-binding EF hand.
Yost JC; Sage EH
J Biol Chem; 1993 Dec; 268(34):25790-6. PubMed ID: 8245016
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of extracellular proteins is correlated with angiogenesis in vitro.
Iruela-Arispe ML; Hasselaar P; Sage H
Lab Invest; 1991 Feb; 64(2):174-86. PubMed ID: 1705300
[TBL] [Abstract][Full Text] [Related]
20. Purification of biologically active SPARC expressed in Saccharomyces cerevisiae.
Yost JC; Bell A; Seale R; Sage EH
Arch Biochem Biophys; 1994 Oct; 314(1):50-63. PubMed ID: 7944407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
